More Argent Biopharma Ltd news
Argent Biopharma LtdASX: RGT

March quarterly activity and cashflow report

Apr 26, 2021 at 10:43 PM EDT · Issued by Argent Biopharma Ltd

Filed with ASX · Apr 26, 2021 at 10:43 PM EDT · 11 pages · English

On 6ix: 6ix.com/news/march-quarterly-activity-and-cashflow-report-3

Argent Biopharma Ltd on 6ix

Earlier from Argent Biopharma

  • MGC pharma to acquire medical research company MediCaNLApr 21, 2021
  • Investor presentationApr 9, 2021
  • Mxc completes first ArtemiC order, March qtr record revenueApr 6, 2021
  • Ethics Committee Approval Granted Phase III Clinical TrialMar 22, 2021
  • SwissPharmaCan AG increases initial purchase orderMar 2, 2021

Later from Argent Biopharma

  • ArtemiC submitted to Health CanadaApr 28, 2021
  • $1M order for ArtemiC Rescue from swiss PharmaCanMay 3, 2021
  • Further findings on ArtemiC as anti-inflammatory agentMay 7, 2021
  • CimetrA patent submitted to European IP officeMay 17, 2021
  • MGC pharma 2021 clinical trials program updateMay 24, 2021
All Argent Biopharma news releases↗

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer